Hemochromatosis Clinical Trial
Official title:
Therapeutic Erythrocytapheresis as Treatment for Hemochromatosis Patients.
In this project we plan to evaluate the effectiveness of erythrocytapheresis against phlebotomy, both regarding the impact on the reduction in iron overload as well as reduction in patient "burden". Aspects of cost effectiveness will be included in the final analysis. Results of the study would allow decision-making based on Evidence Based Medicine on the "best" therapeutic options available for newly-diagnosed as well as existing primary hemochromatosis patients.
In this project we plan to evaluate the effectiveness of erythrocytapheresis against phlebotomy, both regarding the impact on the reduction in iron overload as well as reduction in patient "burden". Aspects of cost effectiveness will be included in the final analysis. The results of the study would allow decision-making based on Evidence Based Medicine on the "best" therapeutic options available for newly-diagnosed as well as existing primary hemochromatosis patients. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00199628 -
Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
|
||
Completed |
NCT03654794 -
Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells
|
||
Terminated |
NCT00122980 -
Stroke With Transfusions Changing to Hydroxyurea
|
Phase 3 | |
Withdrawn |
NCT01892644 -
Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT01524757 -
Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis
|
N/A | |
Completed |
NCT00349453 -
Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
|
Phase 2 | |
Recruiting |
NCT03743272 -
Repeatability and Reproducibility of Multiparametric MRI
|
||
Recruiting |
NCT06137079 -
"Iron Overload and Endocrinological Diseases"
|
||
Completed |
NCT00712738 -
Oral Nifedipine to Treat Iron Overload
|
Phase 1 | |
Completed |
NCT00001455 -
Iron Overload in African Americans
|
N/A | |
Completed |
NCT00006312 -
Hemochromatosis--Genetic Prevalence and Penetrance
|
N/A | |
Completed |
NCT00005559 -
Statistical Basis for Hemochromatosis Screening
|
N/A | |
Recruiting |
NCT00509652 -
Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
|
N/A | |
Completed |
NCT00350662 -
Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
|
Phase 3 | |
Completed |
NCT00005541 -
Hemochromatosis and Iron Overload Screening Study (HEIRS)
|
N/A | |
Completed |
NCT00000595 -
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
|
Phase 2 | |
Completed |
NCT04631718 -
MRI QSM Imaging for Iron Overload
|
||
Active, not recruiting |
NCT00007150 -
Treatment of Hemochromatosis
|
Phase 2 | |
Completed |
NCT00587535 -
Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration
|
N/A | |
Enrolling by invitation |
NCT02025543 -
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
|